Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: unknown, P. 140452 - 140452
Published: Oct. 1, 2024
Language: Английский
Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: unknown, P. 140452 - 140452
Published: Oct. 1, 2024
Language: Английский
International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 277, P. 134347 - 134347
Published: July 31, 2024
Language: Английский
Citations
16European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 275, P. 116589 - 116589
Published: June 12, 2024
Language: Английский
Citations
6Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 151, P. 107671 - 107671
Published: July 23, 2024
Language: Английский
Citations
5RSC Advances, Journal Year: 2025, Volume and Issue: 15(2), P. 1391 - 1406
Published: Jan. 1, 2025
New insecticidal agents based on quinoxaline derivatives targeting the cotton leafworm, Spodoptera litura .
Language: Английский
Citations
0Drug Development Research, Journal Year: 2025, Volume and Issue: 86(2)
Published: March 28, 2025
ABSTRACT Recently, there has been an increasing interest in the use of protein kinase inhibitors as a therapeutic strategy for treatment cancer. In this study, new series 2 H ‐chromene derivatives ( ‐ 5 and 6 8 ) 3 ‐benzo[ f ]chromene carbohydrazide derivative 9 were synthesized. The structure designed was characterized by IR, 1 H/ 13 C NMR, elemental analysis. Moreover, cytotoxic activity newly synthesized chromenes evaluated against breast cancer cell lines (MDA‐MB‐231 MCF‐7) cervical line (HeLa). results these evaluations demonstrated promising activity, ranging from good to moderate. Additionally, lung fibroblast (WI‐38), normal line, also utilized assess active derivatives' selectivity. Among compounds tested, chromene highest potency, exhibiting IC 50 values 5.36 ± 0.50, 7.82 0.60, 9.28 0.70 µM MDA‐MB 231, MCF‐7, HeLa lines, respectively. potential chromone multi‐targeted anticancer agent assessed evaluating its BRAF VEGFR‐2. Notably, most significant VEGFR2 with value 0.224 compared sorafenib's 0.045 µM, while inhibitory 1.695 relative Vemurafenib's 0.468 µM. addition, compound inhibits DHFR enzyme 2.217 0.014 methotrexate (IC = 0.4315 0.019 µM). These revealed that multifaceted mechanisms action may augment effectiveness. causes overexpression caspase‐3 Bax 6.13 8.85‐fold, It downregulates antiapoptotic Bcl‐2 level 0.4775‐fold untreated 231 cells. Flow cytometry analysis MDA‐MB‐231 cells indicates induces cycle arrest G0‐G1 phase, observed percentage 73.15%. in‐silico toxicity prediction profile. Finally, molecular docking studies supported findings confirming strong binding affinities VEGFR‐2, BRAF, DHFR.
Language: Английский
Citations
0Organic & Biomolecular Chemistry, Journal Year: 2024, Volume and Issue: 22(31), P. 6385 - 6392
Published: Jan. 1, 2024
A silver-catalyzed oxidative protocol for the synthesis of previously unfamiliar 4,5-fused coumarins is disclosed.
Language: Английский
Citations
1Chemistry & Biodiversity, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 23, 2024
Abstract HIV‐1 remains a major health problem worldwide since the virus has developed drug‐resistant strains, so, need for novel agents is urgent. The protein reverse transcriptase plays fundamental role in viruses’ replication cycle. FDA approved Delavirdine bearing sulfonamide moiety, while thiazolidinone demonstrated significant anti‐HIV activity as core heterocycle or derivative of substituted heterocycles. In this study, thirty new derivatives (series A, B and C) group were designed, synthesized evaluated their RT inhibition predicted by computer program PASS taking into account best features available NNRTIs well against SARS‐COV‐2 main protease. Seven compounds showed good inhibitory activity, with two them, C1 C2 being better (IC 50 0.18 μΜ & 0.12 respectively) than reference drug nevirapine 0.31 μΜ). evaluation molecules to inhibit protease revealed that 6 exhibited excellent moderate them (B4 B10) having IC values (0.15 0.19 inhibitor GC376 0.439 docking studies coincides experimental results, showing binding mode both enzymes.
Language: Английский
Citations
1Structural Chemistry, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 24, 2024
Language: Английский
Citations
1Archiv der Pharmazie, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 10, 2024
Abstract Developing new molecular entities is one of the most emerging research areas in field Medicinal Chemistry. Over past few years, rigorous has been conducted on sulfaguanidine‐linked synthetic molecules because their promising potential several biological activities. Sulfaguanidine actively incorporated design anticancer, antimicrobial, antidiabetic, antiparkinsonian, anti‐inflammatory, and antiviral candidates. The construction these effective candidates adopted many chemical approaches. A number prepared compounds displayed results that merit further investigations for development medications. This review summarizes different strategies reported activities throughout 2020–2024.
Language: Английский
Citations
1Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: unknown, P. 140452 - 140452
Published: Oct. 1, 2024
Language: Английский
Citations
0